Olanzapine Viatris

Olanzapine, the active ingredient in Olanzapine Viatris, is an atypical antipsychotic presented as a strength/form for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents. GNH USA supplies Olanzapine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olanzapine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapine Viatris is an atypical antipsychotic that modulates neurotransmitter activity in several psychiatric conditions.

- Schizophrenia: helps reduce positive and negative symptoms and prevents relapse. - Bipolar I disorder (manic episodes): assists with mood stabilization and reduces manic symptoms. - Schizoaffective disorder: allevi of both psychotic and mood symptoms. - Psychotic depression: augments antidepressant therapy by addressing psychotic features. - Tourette syndrome: less commonly used to lessen motor and vocal tics. - Agitation associated with schizophrenia or bipolar disorder: provides rapid calming effects.

Olanzine       …  …  ....  t  ....  ....  .... ....  ....  ....  ...  …  … ...  ... ... 

Common   g   g :   t   g ":[  ewline   ewline   ewline  ewline  ewline  ewline \\